Comment on ‘Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer’

Gastric Cancer · Published 2026-06-14 · DOI 10.1007/s10120-026-01770-7

Authors (3)

Xuezhe Yuan, Kaibo Guo, Song Zheng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yuan, X., Guo, K., Zheng, S. (2026). Comment on ‘Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer’. Gastric Cancer. https://doi.org/10.1007/s10120-026-01770-7

Related articles